Wall Street meets AI — but who profits? Major private equity firms are partnering with AI giants like OpenAI, Anthropic, and Google to accelerate AI adoption across their healthcare portfolio companies. Critics warn this mirrors past PE patterns where efficiency gains flowed to investors rather than patients or workers. Healthcare workers are being urged to ask hard questions now — before the tools arrive.
Some of the world's largest private equity (PE) firms — including those tied to healthcare employers like LifePoint Health, Aveanna Healthcare, and Aspen Dental — have recently announced partnerships with AI companies such as OpenAI, Anthropic, and Google. These aren't just software purchases; they're strategic relationships designed to push AI adoption across hundreds of portfolio companies, many of which employ large administrative and support workforces that are prime targets for automation.
The concern isn't AI itself — it's the incentive structure behind it. PE firms have a well-documented history of extracting financial value from healthcare companies (see: Steward Health Care's collapse, Prospect Medical Holdings' struggles) while leaving patients, workers, and communities to absorb the fallout. Critics argue the same dynamic could play out with AI: efficiency gains captured by investors, while staffing and care quality suffer.
Key Takeaways:
Why it matters: With hundreds of thousands of healthcare jobs potentially affected, clinicians and healthcare workers are being urged to proactively ask how AI-generated savings will be used — and whether patients and staff will actually benefit.
